UBS (Lux) Equity Fund - Biotech K-1 Fonds
4.970.258,90
USD
+5867,70
USD
+0,12
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,34% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,68% |
| Neurocrine Biosciences Inc | US64125C1099 | 5,37% |
| Guardant Health Inc | US40131M1099 | 4,39% |
| Amgen Inc | US0311621009 | 4,25% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,23% |
| Moderna Inc | US60770K1079 | 3,85% |
| AbbVie Inc | US00287Y1091 | 3,78% |
| Denali Therapeutics Inc | US24823R1059 | 3,67% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,57% |
| Sonstige | 50,87% |